KAIROS PHARMA LTD (KAPA)

US48301N1046 - Common Stock

1.51  -0.62 (-29.11%)

Premarket: 1.47 -0.04 (-2.65%)

Free users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

 TTM
(2024-9-30)		 2023
(2023-12-31)		 2022
(2022-12-31)		 2021
(2021-12-31)
CASH FLOWS FROM OPERATING ACTIVITIES
Net Income
N/A-1.81M-1.05M-2.15M
Depreciation Amortization
N/A160.00K160.00K98.00K
Change In Working Capital
N/A764.00K129.00K1.19M
Interest Paid
N/A437.00K73.00K0.00
Taxes Paid
N/A93.00K437.00K0.00
Other non cash items
N/A969.00K408.00K444.00K
OPERATING CASH FLOW
N/A81.00K-353.00K-412.00K
 
CASH FLOWS FROM INVESTING ACTIVITIES
Other Investing Activity
N/AN/AN/A-109.00K
INVESTING CASH FLOW
N/AN/AN/A-109.00K
 
CASH FLOWS FROM FINANCING ACTIVITIES
Debt Issued/Reduced
N/A0.00895.00K330.00K
Stock Issued/Repurchased
N/AN/AN/A250.00K
Other Financing Activity
N/A-425.00K-178.00K0.00
FINANCING CASH FLOW
N/A-425.00K717.00K580.00K
 
CHANGE IN CASH
N/A-344.00K364.00K59.00K
 
FREE CASH FLOW
Operating Cash Flow
N/A81.00K-353.00K-412.00K
FREE CASH FLOW
N/A81.00K-353.00K-412.00K

All data in USD

Charts